Table 3 Comparison of levels of auto-antibodies between the two groups
Auto-antibodies | Cancer group (n = 51) (positive/total, percentage) | Control group (n = 204) (positive/total, percentage) | P value |
|---|---|---|---|
ANA | 37/37, 100% | 198/200, 99.00% | 1.00 |
Anti-dsDNA | 15/35, 42.86% | 95/180, 52.78% | 0.36 |
Anti-Sm | 5/36, 13.89% | 33/172, 19.19% | 0.63 |
Anti-RO52 | 26/37, 70.27% | 110/172, 63.95% | 0.57 |
Anti-RO60 | 20/37, 54.05% | 110/172, 63.95% | 0.57 |
Anti-SSB | 4/36, 11.11% | 16/172, 9.30% | 0.76 |
Anti-Nuc | 11/36, 30.56% | 70/172, 40.70% | 0.35 |
Anti-His | 7/36, 19.44% | 50/172, 29.07% | 0.31 |
Anti-Rib | 10/36, 27.78% | 58/172, 33.72% | 0.56 |
Anti-nRNP | 11/36, 30.56% | 64/172, 37.21% | 0.57 |